Claros Mortgage Trust walked into its Q1 2026 results with options traders more defensively positioned than at any point in the past year — and the numbers that emerged after the close on May 6 validated that caution.
The clearest pre-print signal was in the options market. The put/call ratio reached 1.90 on May 6, the highest reading of the past 52 weeks and nearly 1.75 standard deviations above its 20-day average of 0.82. That ratio had risen sharply from near zero in mid-April, a rapid rotation from calls to puts that reflected growing unease about credit conditions heading into the release. The stock had climbed 12% over the prior month to $2.63, making the defensive options activity all the more notable against a backdrop of recent price recovery.
The results themselves were stark. CMTG reported Q1 adjusted EPS of -$0.52, missing the consensus estimate of -$0.17 by a wide margin. Revenue came in at $29.5 million, below the $35.0 million the Street was looking for. The bear case had centred on precisely these risks: ongoing book value erosion, challenging credit conditions across the commercial real estate loan portfolio, and lower-than-expected originations and investment yields. The stock already trades at roughly 0.23 times book value — a level that reflects deep market scepticism about near-term profitability. With the mean analyst price target at $2.50 and the current price at $2.63, the consensus offers essentially no upside buffer following the recent rally.
Short interest tells a less crowded story. At 2.2% of free float, bears have not loaded up aggressively; the position has actually fallen around 10% over the past month. Borrow conditions reinforce that picture — cost to borrow dropped sharply to 0.31% from roughly 0.54% a week earlier, and availability remains ample. Short sellers were not the primary source of pressure heading into the print.
Insider activity from earlier in the year provided a contrasting signal worth noting. In late February and early March, CEO Richard Mack and CFO Mike McGillis each bought shares at prices between $2.28 and $2.41. That cluster of purchases — roughly 95,000 net shares acquired in the 90 days to early March — represented a meaningful show of management confidence at levels below where the stock subsequently traded. The Q1 miss now tests whether that conviction holds. The May 7 conference call is less about whether the CRE lending backdrop is improving, and more about whether management can articulate a credible path to stabilising book value and credit performance in a market that has consistently punished the stock for falling short.
See the live data behind this article on ORTEX.
Open CMTG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
